Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

BMB. 2022; 7(3): 262-266


Evaluation of the relationship between axillary lymph node involvement with frequently evaluated prognostic factors in breast cancer.

Deniz Özel, Mehmet Öncü.




Abstract

Objective: We aimed to evaluate the effect of hormone receptor and immunohistochemistry data on the incidence of primary tumor type and lymph node positivity in breast cancer cases.
Method: Demographic, immunohistochemical data of 62 patients who were biopsied in the institute's interventional radiology clinic and long axis of primary tumor in USG were retrospectively evaluated.
Results: The age of the patients, cell type, c-erb B-2 score and axillary lymph node positivity were not significantly correlated with the assessed data, whereas the long axis of primary tumor, estrogen and progesterone receptor severity and prevalence, KI 67 proliferation index affected lymph node involvement ratio.
Conclusion: Evaluation of lymph node involvement with second-line detailed USG before the operation, especially in malignant tumors refer to surgical or interventional radiology departments with negative, high KI 67 PI and C-erb B-2 values in estrogen and progesterone receptors, and the presence of recent axillary USG examination of the cases for breast biopsy regardless of the results, will provide important contribution in the diagnosis and treatment stages.

Key words: Breast cancer, hormone receptors, immunohistochemical data, axillary lymph node






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.